PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)

Completed · Early Phase 1

Conditions studied: Atherosclerosis

In brief

This study is designed to assess the safety, biodistribution and dosimetry of the novel atherosclerotic imaging PET radiotracer, Cu\[64\]-25%-CANF-Comb.

Key facts

Study ID

NCT02498379

Run by

Washington University School of Medicine

People needed

8

Starts

2014-10-01

Expected to finish

2015-04-01

Last updated by the study team

2016-04-28

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers (4 men and 4 women)
• No evidence of cardiovascular disease and not under care of a physician for any active medical condition
• Health status confirmed by physical exam and ECG
• Signed informed consent

You may not qualify if…

• Pregnancy or lactation
• Inability to lie still for up to 60 min with arms above head for PET-CT imaging
• Unwilling to comply with study procedures and unavailable for the duration of the study.
• Inability to provide written informed consent.

Where it is running

• Washington University in St.Louis — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.